Winning with Sports Celebrities

Hallahan, Mary
July 2000
Pharmaceutical Executive;Jul2000, Vol. 20 Issue 7, p118
Trade Publication
Discusses the popularity of the use of athletes by pharmaceutical companies to promote their health products. Reason behind the trend; Comments from Marc Reede, president of the Nationwide Speakers Bureau.


Related Articles

  • Tight leash. Lentz, Rebecca // Modern Physician;Nov99, Vol. 3 Issue 11, p10 

    Talks about restrictions placed on drug representatives in the United States. Concerns over the liability of having myriad samples around the doctor's office; Drug samples that can be left in the sample closet; How drug representatives reacted to the restrictions.

  • Pharma Code Awareness Grows.  // Review of Ophthalmology;Apr2003, Vol. 10 Issue 4, p10 

    Reports that the pharmaceutical industry has done a fair job of educating its members on the details of the code of the Pharmaceutical Research and Manufacturers of America on marketing and promotion of drug products in the United States. Need for eye surgeons to better understand the code;...

  • Pharmaceutical product ID: An industry in crisis? Levin, Aaron // Drug Topics;9/3/2001, Vol. 145 Issue 17, p42 

    Focuses on the influence of the quantity of drug dispensed on reimbursements or rebates in the United States. Problems of pharmacists in dispensing drugs; Complains on the use of nonstandard packaging by manufacturers; Goals of the National Council for Prescription Drug Programs.

  • A prescription for better prescriptions. Woosley, Raymond L. // Issues in Science & Technology;Spring94, Vol. 10 Issue 3, p59 

    Discusses the dependency of physicians on drug companies as the primary source of information about pharmaceuticals. High cost of marketing; Bias scientific literature; Prescribing practices of physicians; Establishment of federally funded centers for education and research in therapeutics...

  • Using market models to forecast demand for ethical pharmaceuticals. Latta, Michael // Journal of Business Forecasting Methods & Systems;Spring98, Vol. 17 Issue 1, p3 

    Discusses the use of market models to forecast demand for ethical pharmaceutical products. Scenarios to consider in forecasts; Creation of a base case using the patient market model; Need for management approval for assumptions used in the model.

  • Rx.  // Drug Topics;6/7/99, Vol. 143 Issue 11, p55 

    Offers information on several prescription drugs in the United States. Indications of Ovide; Reason for the labeling change of Isuprel; Information on some generic drugs.

  • Distant drumming. Koberstein, Wayne // Pharmaceutical Executive;Nov98, Vol. 18 Issue 11, p12 

    Discusses issues regarding direct-to-consumer (DTC)-promoted products in the pharmaceutical industry. Concerns on DTC marketing; Highlights of the WorldPharm conference held September 1, 1998.

  • Patient Compliance. Loden, D. John; Schooler, Caroline // Pharmaceutical Executive;Jul2000, Vol. 20 Issue 7, p88 

    Discusses how pharmaceutical marketers can improve their rate of patient retention and increase return on their direct-to-consumer (DTC) spend. Information on a study of drug compliance of older adults; Implications of the findings; Importance of patient compliance and retention in DTC...

  • Launching a Blockbuster. Bogan, Christopher; Wang, David // Pharmaceutical Executive;Aug2000, Vol. 20 Issue 8, p96 

    Outlines the strategies pharmaceutical marketers use to create products with high sales curve in the United States. Competitive advantages in the pharmaceutical industry; Overview of product launch trends; Key factors for success.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics